- Home
- GLMD vs IMCC Comparison
GLMD vs IMCC Comparison
Compare GLMD & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLMD | IMCC |
|---|---|---|
| Founded | 2000 | 1980 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4M | 4.1M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GLMD | IMCC |
|---|---|---|
| Price | $0.60 | $0.62 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.2K | ★ 92.4K |
| Earning Date | 04-02-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.50 | $0.54 |
| 52 Week High | $2.67 | $7.12 |
Technical Indicators
Market Signals| Indicator | GLMD | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 32.51 |
| Support Level | $0.50 | N/A |
| Resistance Level | $0.69 | $1.05 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 15.65 | 11.03 |
Price Performance
Historical ComparisonAbout GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.